SCHEMBL19080940

SCHEMBL19080940

CC1(C)c2ccccc2-c2c(-c3ccc(-c4c5ccccc5c(-c5cccc6ccccc56)c5ccccc45)c4ccccc34)cc3c(oc4c5ccccc5ccc34)c21

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARSA P15289 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25C P30307 1/20 0.36
KMT2A Q03164 1/20 0.36
CYP1A1 P04798 7/20 0.34
CYP1A2 P05177 7/20 0.34
CYP1B1 Q16678 7/20 0.34
PRKDC P78527 4/20 0.34
CYP3A4 P08684 2/20 0.34
TSHR P16473 2/20 0.34
CYP2C19 P33261 2/20 0.34
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 3/20 0.32
ALDH1A1 P00352 2/20 0.32
ALOX15 P16050 2/20 0.32
HSD17B10 Q99714 2/20 0.32
HTT P42858 1/20 0.32
PDE5A O76074 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080666 0.95 KMT2A (0.37) ARSACDC25ACDC25CKMT2ACYP1A1
SCHEMBL19077091 0.89 MAOA (0.33) ARSACDC25ACDC25CKMT2ACYP1A1
SCHEMBL19080849 0.89 CYP1A1 (0.35) KMT2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL19080960 0.88 CYP1A1 (0.37) KMT2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL19077108 0.87 MAOA (0.32) ARSACDC25ACDC25CKMT2AMAOA
SCHEMBL19080682 0.87 CYP1A1 (0.39) KMT2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL19080902 0.87 CYP1A1 (0.38) ARSACDC25ACDC25CKMT2ACYP1A1
SCHEMBL24341353 0.85 ALOX5 (0.38) ARSACDC25ACDC25CKMT2APRKDC
SCHEMBL19080725 0.85 CYP1A1 (0.41) KMT2ACYP1A1CYP1A2CYP1B1PRKDC
SCHEMBL19080942 0.83 ARSA (0.34) ARSACDC25ACDC25CKMT2ACYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ARSA 4543/4885CDC25A 71/4885CDC25C 211/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ARSA 4543/4885CDC25A 71/4885CDC25C 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.